By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ariana Pharma will provide its biomarker data mining technology to the US Food and Drug Administration for its efforts to develop better tools for analyzing genomic data to be used in personalized medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.